- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05503823
Investigating Transcranial Alternating Current Stimulation (tACS) Preconditioning Effects on Resting and Active Motor Threshold
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
When volunteers are interested in participating in the study and they contact the PI or RA, the PI or RA will briefly explain the study. If the participant is still interested in participating, two 2-hour time slot will be scheduled for the participant to visit the lab. At the scheduled first visit, the PI or RA will provide and explain each part of the consent from. Once the participant is ready to participate, they will be asked to sign the consent form and will be provided a copy of the signed consent form. The PI or RA will assign a code to each participant. The code will be in the form of XY-RMT_##, where XY are the first letters of the first and last names and ## is a two digit number. After the consent form is signed, it will be placed in a locked cabinet located in our supervisor's office at Riverview Health Center.
Once the participant is fully enrolled, the RA and PI conduct the Montreal Cognitive Assessment (MoCA) and the Questionnaire to determine if the participant meets the inclusion criteria. If the participants have no health or physical conflicts with the application of electrical and magnetic stimulation and have a MoCA score higher than 26 out of 30, the PI and RA will set up the participant and the devices. Using our neuronavigation system in the TMS lab (at Riverview Health Center), a tracking headband will be placed on the participant and a tracker is used to measure the scalp and determine anatomical positions. Electrodes will also be placed on the participants first dorsal interosseous (FDI) muscle of the participant's right hand to record the electromyography (EMG).
The TMS device is the Magstim Rapid 2 Stimulator on single pulse setting with the figure-of-eight coil AirFilm Coil. The EMG device is the EMG Recording Pod from Brainsight 2. The tACS device is the Soterix Medical Inc. tES (transcranial electrical stimulation) (Model: 2001).
For the resting motor threshold (RMT), the PI exposes the participant's C3 section of the brain (area of the left hemisphere of the brain in 10 20 model which is related to the hand area of the primary motor cortex) to single pulses of TMS starting at 50% intensity of the maximum intensity available. This is done while the right hand is at a resting (relax) position. The RA will increase the intensity by increments of 5% until a visible twitch in the right hand is observed. Then the intensity will be decreased by decrements of 1% until 10 consistent visible twitches are observed in arrow. The minimum intensity is recorded as the RMT and the exact position and direction of the coil relative to the headband will be recorded as the target "hotspot" via the neuronavigational system (Vicra position sensor camera). The 10 consecutive successful EMGs will be recorded as the pre-priming data of the resting muscle. A similar procedure will be followed for the active motor threshold (AMT) with the only difference being the condition of the right hand. For an active recording, the participant will be asked to gently grab the arm rest of the chair so the muscle is activated 10-30% of maximal voluntary contraction and the 10 pulses will be exposed to the "hotspot as located by the Vicra camera.
To prime the brain using the tACS, the participant will be given a 5-minute break during which the RA places the active electrode of tACS on the marked "hotspot" and the reference on the contralateral supraorbital area of the head (right side of the forehead above the eyebrow). After the break, the stimulation begins at a frequency of 40 Hz and current intensity of 0.75 mA amplitude for duration of 10 minutes. Immediately after the stimulation the EMG will be recorded through 10 TMS pulses on active FDI muscle and 10 pulses with resting FDI muscle. The same procedure will be followed once 30 minutes after tACS stimulation and once after 1 hour. Similar procedure will be done for the right side RMT/AMT measurement which moves the left hand.
Overall, there will be 40 resting EMG recordings and 40 active EMG recording for each participant. The resting EMG recording will be compared at each time interval for any observable difference in average motor evoked potential (MEP) and the active EMG recordings are compared for difference in both the silence period which appears after the involuntary twitch and the MEP.
The same process will be done for a second time either 4 hours after the first session or on a different day. The only difference being that the participant receives 10 minutes of tRNS instead of tACS.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Manitoba
-
Winnipeg, Manitoba, Canada
- Riverview Health Centre
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Montreal Cognitive Assessment score greater than or equal to 26
Exclusion Criteria:
- being pregnant
- having any metallic implants in the head or upper body
- having a pacemaker
- having a history of seizures
- having a diagnosed major psychotic disorder
- having any nervous system medication (depression, anxiety, sleep, pain, etc.) on a daily basis
- having a brain injury
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Participants
Each participant will have their resting and active motor threshold measured using the transcranial magnetic stimulation (TMS) device.
Participants will receive tACS for 10 minutes in the first session and tRNS in the second session.
|
A light electrical current will be applied to the scalp of the participants via 2 electrodes.
The resting and active motor threshold will be measured before, right after, after 30 minutes, and after 1 hour of receiving the tACS or tRNS.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Resting Motor Threshold
Time Frame: Before tACS, right after tACS, 30 minutes after tACS, and 1 hour after tACS
|
The peak-to-peak amplitude of the muscle signal from the resting motor threshold.
|
Before tACS, right after tACS, 30 minutes after tACS, and 1 hour after tACS
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Active Motor Threshold
Time Frame: Before tACS, right after tACS, 30 minutes after tACS, and 1 hour after tACS
|
Cortical silent period measured post-MEP.
|
Before tACS, right after tACS, 30 minutes after tACS, and 1 hour after tACS
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- HS25595 (B2022:070
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Understand the Effects of tACS on the Brain
-
University of ManchesterSuspendedThe Effects of Cerebellar rTMS on the BrainUnited Kingdom
-
Rennes University HospitalCompletedEffects of Neurotoxicants on the BrainFrance
-
University of TehranKarolinska InstitutetCompletedThe Effects of Educational Intervention on Nurses PerformanceIran, Islamic Republic of
-
Mark GlaisterNot yet recruitingThe Focus of the Study is to Investigate the Effects of Phosphatidylserine Supplementation on Exercise Physiology and Cycling Time-trial Performance
-
Zhongnan HospitalRecruitingInvestigating the Effects of Periocular Acupressure on Ocular Biological IndicatorsChina
-
Near East University, TurkeyCompletedTo Study the Effects of Protein Supplements on Blood TestsCyprus
-
African Strategies for HealthUnited States Agency for International Development (USAID)UnknownEffects of the SMS Mother Reminder System on Use of Health Care.Uganda
-
University of California, IrvineWithdrawnThe Effects of Exercise on Executive FunctionsUnited States
-
Ain Shams UniversityCompletedAdverse Effects in the Therapeutic Use of Other and Unspecified Agents Primarily Acting on the Respiratory System
-
OSF Healthcare SystemUniversity of Illinois College of Medicine at PeoriaCompletedthe Focus of the Clinical Trial is on the Brain Temperatures in Normal Human SubjectsUnited States
Clinical Trials on tACS or tRNS and TMS
-
Università Vita-Salute San RaffaeleAlessia Santoni; Sara Stottmeier; Klara Hemmerich; Giuseppe Di Dona; Luigi Ferini-StrambiNot yet recruitingHuman Brain and Cognition
-
University of MichiganRecruiting
-
Bambino Gesù Hospital and Research InstituteEnrolling by invitationDevelopmental DyslexiaItaly
-
Gen ShinozakiWithdrawn
-
University Hospital Inselspital, BerneCompletedHemispatial NeglectSwitzerland
-
University of ManchesterCompleted
-
Masaryk UniversitySwiss Federal Institute of TechnologyRecruitingHealthy Aging | Mild Cognitive ImpairmentCzechia
-
National Institute of Neurological Disorders and...CompletedMotor Function of Healthy PhysiologyUnited States
-
Christian RuffNot yet recruitingBehavior and Behavior Mechanisms
-
Institut GuttmannRecruiting